The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference CallGlobeNewsWire • 07/27/26
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving LiquidityGlobeNewsWire • 07/07/26
The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?Zacks Investment Research • 06/29/26
How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%Zacks Investment Research • 06/09/26
Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For MondayBenzinga • 06/08/26
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring ConferenceGlobeNewsWire • 05/26/26
The Oncology Institute to Participate in B. Riley Securities Institutional Investor ConferenceGlobeNewsWire • 05/13/26
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue EstimatesZacks Investment Research • 05/08/26
Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2026GlobeNewsWire • 05/05/26
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference CallGlobeNewsWire • 04/27/26
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026GlobeNewsWire • 03/12/26
U.S. Neurology Associates Partners with M33 Growth to Transform Neurological CareGlobeNewsWire • 01/09/26